BMS-813160
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
| Catalog Number | T4584 |
| Alternative Name(s) | BMS 813160 |
| Research Area | Immunology/Inflammation|||Microbiology/Virology |
| Molecular Formula | C25H40N8O2 |
| CAS# | 1286279-29-5 |
| Purity | 99.66% |
| SMILES | CC(C)(C)N[C@@H]1CC[C@@H]([C@H](NC(C)=O)C1)N4CC[C@H](Nc2ncnc3cc(nn23)C(C)(C)C)C4=O |
| Size | 10 mg |
| Supplier Page | https://www.targetmol.com/compound/BMS-813160 |
| Additional Information | https://www.targetmol.com/datasheet/T4584 |